Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03245736
Title Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Genmab
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Brian Slomovitz Miami Florida 33136 United States Details
Johann de Bono Chelsea SM2 5PT United Kingdom Details
Beatson Cancer Centre Glasgow United Kingdom Details
Fiona Thistlethwaite Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from for the field